Company intelligence / Profile preview

AlzLife

Ownership: Private
Development stage: Other

Overview

Early human studies indicate that daily 40Hz light and sound stimulation sessions combined with cognitive exercises can produce measurable improvements in memory, brain connectivity, sleep, and daily activity; notable effects include less ventricular dilation and hippocampal atrophy, with improved performance on memory tests

Therapeutic areas: Neurology
Modalities: DeviceDigital therapeuticNon-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on AlzLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlzLife.

Explore the full profile